» Articles » PMID: 20807884

The Effect of Dietary Patterns on Estimated Coronary Heart Disease Risk: Results from the Dietary Approaches to Stop Hypertension (DASH) Trial

Overview
Date 2010 Sep 3
PMID 20807884
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The Dietary Approaches to Stop Hypertension (DASH) diet is recommended in the 2005 US Dietary Guidelines. To understand the potential benefits of DASH on coronary heart disease (CHD), we applied the Framingham risk equations to calculate 10-year risk of developing CHD using data from the DASH trial.

Methods And Results: In the DASH trial, 459 individuals with prehypertension or stage-1 hypertension not taking antihypertensive medication were randomly assigned to 1 of 3 diets: control, fruits and vegetables (F/V), or DASH (rich in fruits, vegetables, low-fat dairy, and reduced in fats and cholesterol). Weight was held constant. Estimated 10-year CHD risk was the primary outcome of this secondary analysis. Among 436 participants with complete data, mean (SD) age was 44.7 (10.7) years, 51% were male, and 60% were African-American. Median 10-year CHD risk was 0.98% at baseline and decreased in all groups. Compared with control, the relative risk ratio comparing 8-week with baseline 10-year CHD risk was 0.93 (95% confidence interval, 0.85 to 1.02; P=0.12) for F/V and 0.82 (95% confidence interval, 0.75 to 0.90; P<0.001) for DASH. Comparing DASH with F/V, the relative risk ratio was 0.89 (95% confidence interval, 0.81 to 0.97; P=0.012). With the exception of an interaction between dietary pattern and race suggesting a greater risk reduction in blacks than whites (P for interaction=0.038), results were similar across subgroups.

Conclusions: Compared with control and F/V, the DASH diet reduced estimated 10-year CHD risk by 18% and 11%, respectively. In addition to reducing blood pressure, the DASH diet should substantially reduce the risk of CHD.

Citing Articles

Effects of the Chinese Heart-Healthy Diet (Sichuan Cuisine Version) on the 10-year CVD risk and vascular age: a randomised controlled feeding trial.

Su D, Chen H, Guo Y, Feng Q, Yang M, Cai C Br J Nutr. 2023; 131(6):997-1006.

PMID: 37926909 PMC: 10876454. DOI: 10.1017/S0007114523002416.


Dietary Models and Cardiovascular Risk Prevention in Pediatric Patients.

Capra M, Monopoli D, Decarolis N, Giudice A, Stanyevic B, Esposito S Nutrients. 2023; 15(16).

PMID: 37630854 PMC: 10458109. DOI: 10.3390/nu15163664.


Effects of Mediterranean Diet, DASH Diet, and Plant-Based Diet on Outcomes among End Stage Kidney Disease Patients: A Systematic Review and Meta-Analysis.

Charkviani M, Thongprayoon C, Tangpanithandee S, Krisanapan P, Miao J, Mao M Clin Pract. 2023; 13(1):41-51.

PMID: 36648844 PMC: 9844348. DOI: 10.3390/clinpract13010004.


Effects of Diet on 10-Year Atherosclerotic Cardiovascular Disease Risk (from the DASH Trial).

Jeong S, Wee C, Kovell L, Plante T, Miller 3rd E, Appel L Am J Cardiol. 2022; 187:10-17.

PMID: 36459731 PMC: 10122756. DOI: 10.1016/j.amjcard.2022.10.019.


Cardiac and Mental Benefits of Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) Diet plus Forest Bathing (FB) versus MIND Diet among Older Chinese Adults: A Randomized Controlled Pilot Study.

Yau K, Law P, Wong C Int J Environ Res Public Health. 2022; 19(22).

PMID: 36429384 PMC: 9690744. DOI: 10.3390/ijerph192214665.


References
1.
Obarzanek E, Sacks F, Vollmer W, Bray G, Miller 3rd E, Lin P . Effects on blood lipids of a blood pressure-lowering diet: the Dietary Approaches to Stop Hypertension (DASH) Trial. Am J Clin Nutr. 2001; 74(1):80-9. DOI: 10.1093/ajcn/74.1.80. View

2.
Sacks F, Obarzanek E, Windhauser M, Svetkey L, Vollmer W, McCullough M . Rationale and design of the Dietary Approaches to Stop Hypertension trial (DASH). A multicenter controlled-feeding study of dietary patterns to lower blood pressure. Ann Epidemiol. 1995; 5(2):108-18. DOI: 10.1016/1047-2797(94)00055-x. View

3.
. The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels. Results of the Trials of Hypertension Prevention, Phase I. JAMA. 1992; 267(9):1213-20. DOI: 10.1001/jama.1992.03480090061028. View

4.
. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA. 1991; 265(24):3255-64. View

5.
Wang R, Lagakos S, Ware J, Hunter D, Drazen J . Statistics in medicine--reporting of subgroup analyses in clinical trials. N Engl J Med. 2007; 357(21):2189-94. DOI: 10.1056/NEJMsr077003. View